Outcomes of Antineoplastic Immunotherapy at a Large Healthcare Organization: Impact of Provider, Race and Socioeconomic Status.

Matthew M Mirsky,Carley Mitchell,Augustine Hong,Shufen Cao,Pingfu Fu,Seunghee Margevicius, Sulin Wu,Afshin Dowlati,Ariel Nelson,J Eva Selfridge,Nikhil Ramaiya,Christopher Hoimes,Asrar Alahmadi,Debora S Bruno

Cancer management and research（2023）

Cited 0|Views28

No score

Abstract

In a large health-care organization, patients treated with checkpoint inhibitors by DOPs benefited from a significant OS advantage that was durable after controlling for racial and socioeconomic factors, providing evidence that disease-oriented care has the potential to mitigate racial and socioeconomic disparities.

Translated text

Key words

antineoplastic immunotherapy,large healthcare organization,socioeconomic status,outcomes

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined